Virbac SA (France) Analysis
VIRP Stock | EUR 324.00 0.50 0.15% |
Virbac SA is overvalued with Real Value of 281.88 and Hype Value of 324.0. The main objective of Virbac SA stock analysis is to determine its intrinsic value, which is an estimate of what Virbac SA is worth, separate from its market price. There are two main types of Virbac SA's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Virbac SA's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Virbac SA's stock to identify patterns and trends that may indicate its future price movements.
The Virbac SA stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Virbac SA's ongoing operational relationships across important fundamental and technical indicators.
Virbac |
Virbac Stock Analysis Notes
About 50.0% of the company outstanding shares are owned by insiders. The book value of Virbac SA was at this time reported as 96.99. The company recorded earning per share (EPS) of 14.05. Virbac SA last dividend was issued on the 24th of June 2022. The entity had 4:1 split on the 30th of July 2002. Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people. For more information please call Marc Bistuer at 33 4 92 08 71 00 or visit https://corporate.virbac.com.Virbac SA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Virbac SA's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Virbac SA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Virbac SA generated a negative expected return over the last 90 days | |
Virbac SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
About 50.0% of the company outstanding shares are owned by insiders |
Virbac Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Virbac SA's market, we take the total number of its shares issued and multiply it by Virbac SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Virbac Profitablity
Virbac SA's profitability indicators refer to fundamental financial ratios that showcase Virbac SA's ability to generate income relative to its revenue or operating costs. If, let's say, Virbac SA is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Virbac SA's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Virbac SA's profitability requires more research than a typical breakdown of Virbac SA's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16. Technical Drivers
As of the 26th of November, Virbac SA has the Coefficient Of Variation of (3,550), risk adjusted performance of (0.01), and Variance of 5.6. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Virbac SA, as well as the relationship between them.Virbac SA Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Virbac SA middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Virbac SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Virbac SA Outstanding Bonds
Virbac SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Virbac SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Virbac bonds can be classified according to their maturity, which is the date when Virbac SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 4875 Corp BondUS55336VAG59 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View |
Virbac SA Predictive Daily Indicators
Virbac SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Virbac SA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Virbac SA Forecast Models
Virbac SA's time-series forecasting models are one of many Virbac SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Virbac SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Virbac Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Virbac SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Virbac shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Virbac SA. By using and applying Virbac Stock analysis, traders can create a robust methodology for identifying Virbac entry and exit points for their positions.
Virbac SA produces and sells medicines and vaccines for companion and food-producing animals. Virbac SA was founded in 1968 and is headquartered in Carros, France. VIRBAC operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 4893 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Virbac SA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Complementary Tools for Virbac Stock analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |